Purpose of the Test
- Determine patient eligibility for immunotherapy drugs.
- Predict the likelihood of tumor response to modern treatments.
- Personalize a precise treatment plan for each cancer patient.
Book PD-L1 Test in Saudi Arabia | Lahalak Medical Platform
PD-L1 testing helps determine your response to advanced immunotherapy, enabling oncologists to select the most effective treatment plan for cancer patients to ensure the best possible clinical outcomes.
Scientific name: PD-L1 Protein Expression Testing (IHC)
An immunohistochemistry (IHC) test that measures PD-L1 protein levels on tumor and immune cells, guiding oncologists in selecting the most effective immunotherapy based on the patient's condition.
Service type
Advanced laboratory test
Duration
20-30 minutes
Fasting
Fasting is not required
Included Services
- Laboratory tissue sample analysis
- Detailed protein expression report
Medical Service Information
Target Groups
- Patients with non-small cell lung cancer (NSCLC).
- Individuals with bladder or kidney cancer.
- Patients with triple-negative breast cancer.
Clinical Importance
- Helps avoid ineffective treatments and their side effects.
- Provides vital information for informed clinical decision-making.
- Serves as a cornerstone in personalized oncology medicine.
Conditions & Notices
- Requires a preserved tissue biopsy block
- Previous medical reports must be provided
Medical services you might also like
